Skye Bioscience Inc SKYE

$1.68 +0.08 (5.00%)

Valuation

Market cap
7,084,000
Revenue TTM
$0
Net income TTM
$-55,920,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
11,100
Avg volume
108,238
Day's range
$1.58 – $1.68
Shares out
4,428,000
Stochastic %K
36%
Beta
2.86
Analysts
Sell
Price target
$60.80

Price

Company profile

Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases. The company's lead clinical asset is nimacimab, a peripherally-restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1) administered as a subcutaneous injectable, which targets CB1 receptors in periphe...

Show more

Skye Bioscience, Inc., a clinical-stage biotechnology company, develops molecules that modulate G-protein-coupled receptors to treat obesity, overweight, and related metabolic diseases. The company's lead clinical asset is nimacimab, a peripherally-restricted negative allosteric modulating antibody targeting cannabinoid receptor 1 (CB1) administered as a subcutaneous injectable, which targets CB1 receptors in peripheral tissues including adipose, liver, and muscle tissues with limited central nervous system accumulation. Nimacimab addresses metabolic processes related to energy expenditure, fat mobilization, leptin sensitivity, appetite regulation, and satiety signaling. Skye Bioscience, Inc. was formerly known as Emerald Bioscience Inc. and changed its name to Skye Bioscience, Inc. in December 2020. Skye Bioscience, Inc. was incorporated in 2011 and is based in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 410 0266
Website
https://skyebioscience.com
Address
11250 El Camino Real, Suite 100, San Diego, United States

Latest news

Stocktwits

LuckyEnzo Oct 1, 5:59 PM
@EquivalentExchange is on an absolute tear recently🔥the plays just keep getting better! If you’re not following yet you’re missing out. $SKYE $TPET $ICCM ready!
0 replies
Fellforit Sep 18, 10:47 PM
$SKYE sec form 4 selling by 5 am venture..
0 replies
martyn78 Sep 18, 7:35 AM
Been tapped into @_ProfessorGamma for a minute now. The way they spot some of these plays before they run is nuts! Wise to be paying attention to this account, give him a proper follow 👍 $OCG & $SKYE looking solid
0 replies
Blinddartthrowerl Sep 18, 12:26 AM
$SKYE I am embarrassed to admit I ever owned this pile of puke 🤮 🤮 🤮
0 replies
Yahtzee27 Sep 17, 7:19 PM
$SKYE toast… you need your head evaluated if you’re buying more
0 replies
Aznnolife1 Sep 17, 11:40 AM
$SKYE From their own SEC filings, - **2011:** Load Guard Transportation — a Nevada *trucking company* - **2012:** Load Guard Logistics - **2014:** a cannabis biotech reverse-merges into the trucking shell → **Nemus Bioscience** - **2019:** renamed **Emerald Bioscience** (cannabis was the hot trend) - **2021:** renamed **Skye Bioscience** (obesity/GLP-1 became the hot trend) Trucking → weed → obesity. Each rename chased whatever story was selling at the moment.
0 replies
Fellforit Sep 17, 3:31 AM
$SKYE buying opportunities abound.. PD for ceo of the year!!
0 replies
prismmarketview Sep 16, 9:46 PM
A heavy Wednesday: 7 of 27 PRISM indexes finished higher in a session where the selling was broad but shallow, with the damage concentrated in a handful of single names. Women's health (+5.29%), crypto mining (+1.56%) and healthcare (+1.19%) led the gainers, while oil and gas (-4.09%) and weight loss (-2.88%) lagged. Biggest single-stock moves: $PDSB $FEAM +39.68% led the gainers, while $SKYE -19.43%, $FBDT -17.00% and $PALI -16.13% led the decliners. Full board below. Index detail at http://prismmarketview.com
0 replies